Post-acute COVID19 syndrome (PACS) is an umbrella term for a syndrome of symptoms persisting at least 12 weeks post COVID19 infection. Preliminary studies in PACS patients post-hospitalization revealed abnormally low 129Xe RBC-to-barrier ratios, but the clinical relevance of this is not well-understood. We acquired 129Xe gas-transfer MRI, spirometry, diffusing-capacity-of-the-lung for carbon-monoxide (DLCO) and same-day CT in 39 participants including 30 PACS and 9 never-COVID19 controls. The 129Xe MRI RBC-to-barrier ratio was significantly related to DLCO and significantly lower in both never-hospitalized and ever-hospitalized PACS patients compared to never-COVID19 controls.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords